The biotech industry continues active consolidation and expansion through acquisitions, partnerships, and funding rounds. Celltrion announced a $330 million acquisition of Eli Lilly’s cGMP biologics plant, aligning with plans to invest up to $1 billion for expansion. Gifthealth acquired Occam Health, combining digital pharmacy and patient access services to streamline medication delivery. VedaBio extended a $25 million funding round alongside a strategic Siemens Healthineers alliance to enhance decentralized CRISPR diagnostics. Additionally, multiple biopharmas pursued financing rounds to fuel pipeline growth, reinforcing industry momentum despite macroeconomic challenges.